深度静脉经导管动脉化后血流动力学变化与创面愈合的量化
本研究基于PROMISE II前瞻性多中心队列,分析105例无选项慢性肢体威胁性缺血患者接受深度静脉经导管动脉化(TADV)后的纵向血流动力学与创面愈合。1年保肢率68.7%,愈合/愈合中达75.5%;双功超声示高阻力波形比例从基线7.9%升至1年81.1%(P < .0001),高阻力电路患者愈合/愈合中达86.7%。
要点
- TADV术后电路呈阶段性成熟,高阻力波形比例1年达81.1%。
- 1年保肢率68.7%,愈合/愈合中伤口达75.5%。
- 高阻力电路患者愈合/愈合中达86.7%,远端灌注指标更优。
核心结论
- TADV通过双功超声证实的阶段性血流动力学成熟促进保肢,支持其在无选项CLTI中的持久获益。
研究设计与样本
- PROMISE II(NCT03970538)为前瞻性多中心研究,纳入105例因「沙漠足」动脉解剖无选项CLTI患者。
- 通过标准化方案收集1年临床结局、灌注指标及系列双功超声数据。
主要发现
- 1年保肢率为68.7%。
- 有裁定创面数据的患者中,1年愈合/愈合中为75.5%;恶化状态从52.6%降至14.3%,完全愈合增至46.9%。
- 电路高阻力波形比例从基线7.9%升至3个月24.6%、6个月37.7%、1年81.1%(P < .0001)。
- 1年时高阻力电路患者愈合/愈合中为86.7%,趾臂指数≥0.3为57.1%,趾压≥40 mmHg为78.3%。
关键数值与推荐
- 电路成熟特征包括波形达到高阻力构型及加速时间缩短提示血管重塑。
- 高阻力电路患者1年愈合/愈合中86.7%、趾臂指数≥0.3达57.1%、趾压≥40 mmHg达78.3%。
临床怎么用
- 可将系列双功超声波形阻力类型与加速时间作为TADV术后电路成熟的监测指标。
- 结合趾臂指数与趾压评估远端灌注,辅助判断创面愈合潜力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Transcatheter arterialization of the deep veins (TADV) is a novel therapy for no-option chronic limb-threatening ischemia (CLTI) that delivers oxygenated blood to the foot via the venous system and has demonstrated favorable limb salvage outcomes in several studies, including the Pivotal Revascularization or Limb Restoration in Patients With Chronic Limb-Threatening Ischemia (PROMISE) II trial. The present study characterizes circuit maturation in the PROMISE II cohort by examining its longitudinal hemodynamic development and associated wound healing, with the goal of better defining the mechanism of action of TADV. METHODS: PROMISE II (NCT03970538) was a prospective, multicenter study on TADV in patients with no-option CLTI due to "desert foot" arterial anatomy. The objective was to evaluate longitudinal changes following TADV including hemodynamics from duplex ultrasound, distal perfusion, and wound healing over time. Clinical outcomes, perfusion metrics, and serial duplex ultrasound data were collected through 1 year using standardized protocols. Duplex studies evaluated volume flow and spectral Doppler parameters across the TADV circuit. Distal perfusion was assessed using toe-brachial index and toe pressures. Duplex-derived waveforms were categorized as low resistance or high resistance, and longitudinal hemodynamic changes were analyzed. Circuit maturation was assessed using characteristics such as waveform achieving high-resistance configuration and decreased acceleration time indicating vascular remodeling. RESULTS: A total of 105 patients from PROMISE II were included in the analysis. Limb salvage was 68.7% at 1 year. Among patients with adjudicated wound data, 75.5% were healed/healing at 1 year; patients with worsening status decreased from 52.6% to 14.3%, whereas complete healing increased to 46.9%. Circuits transitioned from low- to high-resistance waveforms (7.9% at baseline; 24.6% at 3 months; 37.7% at 6 months; 81.1% at 1 year; P < .0001). At 1 year, in patients with high-resistance circuits, healed/healing wound status was 86.7%, toe-brachial index ≥ 0.3 was 57.1%, and toe pressure ≥40 mmHg was 78.3% indicating greater distal perfusion. CONCLUSIONS: TADV promotes limb salvage through staged hemodynamic maturation demonstrated by duplex ultrasound, microvascular remodeling, sustaining perfusion, and supporting its durable benefit in no-option CLTI.
引用
- Schneider PA, Dua A, Powell RJ, et al. Quantification of hemodynamic changes and wound healing following transcatheter arterialization of the deep veins in no-option chronic limb-threatening ischemia. J Vasc Surg. 2026. PMID: 42600759. doi:10.1016/j.jvs.2026.08.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。